-
Basel, July 21, 2022 – Sandoz, a global leader in generic and biosimilar medicines, today announced that the US Food and Drug Administration (FDA) has accepted for review its Supplemental Biologics License Application (sBLA) for a high concentration formulation of 100 mg/mL (HCF) of its biosimilar Hyrimoz® (adalimumab-adaz). The application…Access to Healthcare
-
Basel, June 23, 2022 — Novartis endorses the Kigali Declaration on neglected tropical diseases (NTDs) and announces a five-year financial commitment of USD 250 million to the fight against NTDs and malaria in conjunction with the Kigali Summit on Malaria and NTDs alongside the 26th Commonwealth Heads of Government (CHOGM) meeting. This summit…MalariaInfectious DiseasesFuture of HealthcareAfricaAccess to Healthcare
-
Thierry Diagana and Jonathan Spector from the Novartis Institute for Tropical Diseases (NITD) discuss learnings about their work in Neglected Tropical Diseases (NTDs) and share insights into the factors, which could lead to a resurgence of these diseases.
Access to HealthcareClinical ResearchDrug DevelopmentInfectious DiseasesTropical Diseases -
Sickle cell disease disproportionately affects babies in Africa, but many go undiagnosed due to lack of screening. Newborn screening is needed to save lives and improve care.
Access to HealthcareAfricaChildren's HealthNovartis Access -
Raising awareness of the ways in which prostate cancer can affect the sexual minority and gender minority communities.
Access to HealthcareCancerOncologySocial CommitmentTargeted Therapy -
Nairobi, June 2, 2022 – Novartis today announced a partnership with the American Society of Hematology (ASH) to provide six additional African nations with technology that is already being used in Ghana to document and share the diagnosis of babies with sickle cell disease. Early diagnosis is key to managing the disease and ensuring better health…Genetic DiseaseAfricaAccess to Healthcare
-
Basel, May 31, 2022 – Sandoz, a global leader in generic and biosimilar medicines, today announced the launch of a new global initiative called ‘Act4Biosimilars’ to help address health inequity and inequality worldwide. Act4Biosimilars aims to increase patient access to advanced medicines by facilitating greater approvability, accessibility,…Access to Healthcare
-
Low- and middle-income countries will account for some three in four of the world’s cancer deaths within the next decade without better access to care. It’s a gap Amy Israel and her team at Novartis are trying to bridge.
Access to HealthcareCancerNovartis AccessSocial Commitment -
Thierry Diagana and his team are on a quest to discover new therapeutics for malaria. He believes malaria elimination is within our grasp, but emerging drug resistance could jeopardize the hard-fought progress.
Access to HealthcareInfectious DiseasesMalariaMedical InnovationsTropical Diseases -
Access to HealthcareCardiovascular DiseaseHeart DiseaseNovartis Access
-
One patient’s story reveals the hidden obstacles to better health – and opportunities to help clear them.
Access to HealthcareDisease AwarenessGenetic DiseaseLiving With DiseasePatient Voices -
Basel, October 21, 2021 — Novartis announced today that it has signed an initial agreement to leverage its manufacturing capacity and capabilities to address the COVID-19 pandemic by expanding its support of the fill and finish of the Pfizer-BioNTech COVID-19 vaccine. Novartis will use its sterile manufacturing facilities at its Novartis Technical…Global Health PartnershipsDisease AwarenessAccess to Healthcare